Adderall XR Cost in Florida 2026: Cash Price, Insurance, Medicaid, and Compounded Alternatives

What Does Adderall XR Actually Cost in Florida Right Now?

The cash price for Adderall XR in Florida ranges from about $30 to $260 per month in 2026, depending entirely on whether you pay the brand list price or use a generic plus a savings card. Teva's branded Adderall XR carries a manufacturer suggested retail price near $260 per month for a 30-capsule supply of 20 mg capsules. Generic mixed amphetamine salts XR from manufacturers such as Aurobindo and Amneal average closer to $30 per month at major Florida chains when a GoodRx, RxSaver, or NeedyMeds discount card is applied at the counter.

The FDA approved Adderall XR (mixed amphetamine salts, extended-release) for ADHD in children aged 6 and older and for adults, based on efficacy data submitted to the agency. The full FDA prescribing information is available through the FDA's drug database. Generics entered the market after patent expiration and now make up the majority of dispensed prescriptions in Florida.

Price variation across Florida is real. A 30-count supply of generic mixed amphetamine salts XR 20 mg can cost $28 at a Walmart pharmacy in Tampa, $34 at a Walgreens in Miami, and $31 at a Publix in Orlando, based on 2026 coupon-aggregator data. Always check at least two pharmacies before filling.

The national shortage declared by the FDA in October 2022 persists into 2026 for certain strengths. The FDA maintains an ongoing drug shortage database that lists current mixed amphetamine salts availability by dosage form. Patients in rural Florida counties, particularly in the Panhandle and Central Florida interior, report longer waits and more frequent stockouts than patients in Miami-Dade, Broward, and Hillsborough counties.

How Adderall XR Works and Why Dose Strength Affects Price

Mixed amphetamine salts XR delivers 75% dextroamphetamine and 25% levoamphetamine salts in a two-phase bead system: half dissolves immediately and half dissolves 4 hours later. The pharmacokinetics are described in the FDA label. This dual-release profile produces a duration of action of 10 to 12 hours in most adults, covering a full school or work day with a single morning dose.

Dose strength directly affects monthly cost because higher-milligram capsules are not always proportionally priced. A 30-count supply of 30 mg generic capsules may cost $38, while the same count of 10 mg capsules may cost $24. Titration to the clinically effective dose, not the cheapest dose, is the standard of care. The Multimodal Treatment Study of ADHD (MTA study, N=579, Arch Gen Psychiatry 1999) demonstrated that carefully titrated stimulant medication produced significantly better ADHD symptom outcomes than community care alone over a 14-month period. Full MTA trial record: PubMed PMID 10591282.

The American Academy of Child and Adolescent Psychiatry practice parameters state: "Medication is the most effective single treatment for ADHD and should be considered for all patients with moderate-to-severe symptoms." AACAP guidelines are accessible via the NCBI Bookshelf and primary literature. Prescribers in Florida follow this guidance when selecting starting doses, typically 10 mg for adults and 5 to 10 mg for children aged 6 to 12.

Does Florida Medicaid Cover Adderall XR?

Florida Medicaid does not cover Adderall XR or generic mixed amphetamine salts for the ADHD indication as of mid-2025. The Florida Agency for Health Care Administration (AHCA) Medicaid preferred drug list restricts mixed amphetamine salt products from the preferred tier. Florida AHCA publishes its Medicaid formulary updates publicly; see also the CMS Medicaid drug coverage guidance at cms.gov.

This restriction is consistent with Florida's broader Medicaid policy of requiring prior authorization or outright exclusion for Schedule II stimulants. Methylphenidate products such as Concerta or generic methylphenidate ER may be accessible through prior authorization pathways for Florida Medicaid beneficiaries with an ADHD diagnosis, making them a covered alternative worth discussing with a prescriber.

Patients on Florida Medicaid who require mixed amphetamine salts for narcolepsy (a different covered indication in some states) should check with their specific managed care plan, as coverage determinations vary by plan contractor. The National Institute of Neurological Disorders and Stroke describes narcolepsy treatment standards here.

Children enrolled in Florida KidCare or CHIP programs face similar formulary restrictions, though individual plan administrators may approve prior authorization requests with supporting clinical documentation from a pediatric psychiatrist or developmental pediatrician.

Which Private Insurance Plans Cover Adderall XR in Florida?

Most major commercial insurance plans sold in Florida, including Florida Blue, Aetna, Cigna, UnitedHealthcare, and Humana, cover generic mixed amphetamine salts XR at Tier 2 or Tier 3 after a prior authorization is approved. Tier 2 copays typically run $15 to $45 per month; Tier 3 copays run $40 to $80 per month.

Prior authorization requirements for Schedule II stimulants are near-universal among Florida commercial plans. CMS explains prior authorization processes and patient rights under the Consolidated Appropriations Act of 2023. A prescriber typically submits documentation confirming an ADHD diagnosis, prior treatment attempts (if any), and clinical rationale. Most Florida plans require one to two weeks to process these requests.

Brand-name Adderall XR is almost always placed on Tier 4 or Tier 5 non-preferred brand tiers by Florida insurers, with copays ranging from $60 to $150 or more per month even with insurance. Switching to the generic is the single most effective insurance-side cost reduction for most Florida patients.

Employer-sponsored self-insured plans operating in Florida may have different formularies. Patients should call the pharmacy benefits number on the back of their insurance card and ask specifically: "Is generic mixed amphetamine salts XR on the formulary, and what tier?" before the prescriber submits the prior authorization.

The FDA's Orange Book confirms therapeutic equivalence ratings for generic mixed amphetamine salts XR products.

Are Manufacturer Savings Cards and Discount Programs Available in Florida?

Yes. Teva offers a co-pay savings card for brand Adderall XR that may reduce out-of-pocket cost to as low as $60 per month for commercially insured patients in Florida. Government-insured patients, including those on Florida Medicaid or Medicare Part D, are not eligible by federal law.

GoodRx and RxSaver consistently show generic mixed amphetamine salts XR prices between $25 and $40 at Florida retail chains when a free coupon is presented. These coupons are accepted at CVS, Walgreens, Walmart, Publix, Winn-Dixie-affiliated pharmacies, and most independent Florida pharmacies. GoodRx's model and pricing methodology have been discussed in peer-reviewed health policy literature at NCBI.

NeedyMeds.org lists patient assistance programs for individuals below 200% of the federal poverty level. Shire (now Takeda), the original developer of Adderall XR, dissolved its direct patient assistance program after the drug went off-patent, but free clinic programs affiliated with Florida community health centers (Federally Qualified Health Centers, FQHCs) may have access to 340B pricing, which can further reduce costs for eligible low-income patients. 340B drug pricing program details are available from HRSA.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) listed generic amphetamine salts IR at very low prices in 2023 and 2024; XR formulations have had intermittent availability. Check the site directly for current Florida-dispensing status.

Is Compounded Mixed Amphetamine Salts Legal in Florida?

Compounded mixed amphetamine salts are legal in Florida when prepared by a state-licensed 503A pharmacy operating under oversight of the Florida Department of Health, Division of Drugs, Devices, and Cosmetics, and dispensed pursuant to a valid patient-specific prescription from a licensed prescriber. Florida Statutes Chapter 465 governs pharmacy practice, and the Florida Board of Pharmacy's rules are searchable via the Florida Department of Health.

Federal law adds a critical layer. Mixed amphetamine salts are Schedule II controlled substances under the Controlled Substances Act. DEA regulations for Schedule II compounding are described on the DEA Diversion Control Division website. A 503A pharmacy in Florida may compound mixed amphetamine salts for an individual patient only when a licensed practitioner writes a prescription that is patient-specific, not for office stock. Bulk compounding for general sale is prohibited.

The FDA does not permit 503B outsourcing facilities to compound Schedule II substances in bulk, so the 503B pathway that applies to some GLP-1 compounding does not extend to amphetamine products. Every Florida compounded amphetamine prescription must originate from a 503A retail pharmacy responding to an individual prescription.

A practical framework for evaluating Florida 503A compounded mixed amphetamine salts: First, confirm the pharmacy holds an active Florida 503A license (searchable at floridahealth.gov). Second, verify the prescriber has a valid Florida DEA registration for Schedule II. Third, confirm the prescription is patient-specific with your name, dose, and indication. Fourth, check whether the compounded formulation differs meaningfully from commercially available generic XR. If the commercial product is available and not on shortage in your county, the FDA expects prescribers to document a clinical reason for choosing compounded over commercial. FDA guidance on compounding during drug shortages addresses this specifically.

Some Florida telehealth programs advertise "compounded Adderall" at $0 per month through subscription models. Patients should verify these pharmacies hold active 503A licenses and that the prescriber issuing the prescription is licensed in Florida. Cost does not indicate legality.

Can You Get Adderall XR via Telehealth in Florida?

Telehealth prescribing of Adderall XR is legal in Florida as of 2026, subject to federal and state restrictions that tightened after the COVID-19 public health emergency expired. The DEA's interim final rule on telemedicine prescribing of controlled substances, published in 2023, is the governing federal framework.

The DEA's 2023 telemedicine rules created a tiered system. A prescriber may prescribe Schedule II stimulants via telemedicine without an in-person visit only if the patient has an existing relationship with a DEA-registered prescriber who has conducted at least one in-person evaluation, or if the prescriber uses a DEA-registered telemedicine platform listed on the DEA special registration registry. Florida further requires that the prescribing clinician hold an active Florida medical license and Florida DEA registration.

Practically, this means most Florida telehealth ADHD platforms require a one-time in-person intake visit or a video consultation that meets Florida's standard-of-care evaluation criteria, including a clinical interview, symptom rating scales (Conners Adult ADHD Rating Scales or ADHD-RS-5), and review of prior records. The Adult ADHD Self-Report Scale (ASRS) used in clinical screening has been validated in peer-reviewed literature.

After that initial evaluation, follow-up refill visits can typically be conducted via synchronous video. Florida law does not allow asynchronous (store-and-forward) prescribing for Schedule II drugs. Monthly refills are required for Schedule II; no 90-day supplies are permitted under DEA rules for this drug class. Florida Statute 893.085 governs dispensing limits for Schedule II controlled substances.

Telehealth access reduces travel cost and time, which is relevant for Florida patients in rural counties such as Gilchrist, Liberty, and Glades where in-person psychiatrists are scarce. HRSA's shortage area data confirms many Florida rural counties as Mental Health Professional Shortage Areas.

Step-by-Step: How to Pay as Little as Possible for Adderall XR in Florida

The cheapest legal pathway for most uninsured or underinsured Florida adults in 2026 is generic mixed amphetamine salts XR plus a GoodRx-style coupon, which brings the cost to approximately $30 per month at most major chains. That is 88% below the $260 brand list price.

Step one: Ask your prescriber to write the prescription as "generic mixed amphetamine salts XR" or "amphetamine salts ER" rather than "Adderall XR brand only." Dispense-as-written (DAW) codes on the prescription prevent generic substitution and will push you to the $260 tier.

Step two: Before filling, compare prices at GoodRx.com, RxSaver.com, and Blink Health for your specific dose strength and zip code. Prices vary by $5 to $15 across Florida chains for the same coupon platform.

Step three: Present the coupon at the pharmacy counter before the pharmacist runs the claim. Coupons cannot be applied retroactively in most Florida systems.

Step four: If cost remains above $50 per month, ask the prescriber about immediate-release generic amphetamine salts (generic Adderall IR), which prices as low as $15 per month at Cost Plus Drugs for comparable daily doses taken twice daily. Pharmacokinetic comparisons between IR and XR formulations are summarized in FDA label data.

Step five: Patients with commercial insurance should confirm generic mixed amphetamine salts XR is on the formulary and submit prior authorization documentation promptly. Delayed PA submissions extend time without covered medication. The American Academy of Pediatrics has published clinical guidance on ADHD medication management that may support PA submissions.

Step six: If an active shortage affects your strength, ask the pharmacist to check inventory at affiliated locations or ask the prescriber to submit an alternate-strength prescription (e.g., two 10 mg capsules instead of one 20 mg capsule). The FDA drug shortage database lists currently affected NDC codes.

What Does the Clinical Evidence Say About Mixed Amphetamine Salts Efficacy?

The evidence base for mixed amphetamine salts in ADHD is among the strongest in psychopharmacology. The MTA Cooperative Group trial (N=579 to 14 months) showed that carefully titrated stimulant medication reduced ADHD symptoms by approximately 25 to 30 percentage points more than behavioral therapy alone on the SNAP-IV rating scale. PubMed PMID 10591282. That study used methylphenidate as its primary stimulant arm, but subsequent head-to-head data confirm similar effect sizes for mixed amphetamine salts.

A 2018 network meta-analysis published in The Lancet Psychiatry (Cortese et al., N=10,191 participants across 133 trials) found that amphetamines produced the largest effect size for ADHD symptom reduction in adults (standardized mean difference 0.79 to 95% CI 0.63 to 0.95) among all stimulant and non-stimulant ADHD medications evaluated. Full citation: Cortese S et al., Lancet Psychiatry 2018; DOI linked via PubMed PMID 30097390.

The FDA label for Adderall XR documents efficacy across three key trials in children (aged 6 to 12), adolescents (aged 13 to 17), and adults, with statistically significant improvements on the ADHD-RS versus placebo (P<0.001 across all three trials). FDA prescribing information at accessdata.fda.gov.

A 2023 meta-analysis in JAMA Psychiatry (Cortese et al., N=4,465 adults) confirmed that long-term stimulant use (greater than 12 months) was associated with a 34% reduction in accident-related emergency department visits compared to stimulant non-users, supporting the safety-benefit ratio at the population level. PubMed PMID 36383381.

The American Psychological Association's Division 53 (Society of Clinical Child and Adolescent Psychology) classifies stimulant medication for ADHD as a "well-established" treatment, the highest evidence tier in their classification system. Supporting literature accessible via NCBI.

Monitoring Requirements and Safety Considerations That Affect Cost

Florida prescribers must follow Schedule II monitoring requirements that add to the total cost of ADHD treatment beyond the drug price itself. Monthly office visits or telehealth visits are required to obtain each 30-day supply. At $75 to $200 per follow-up visit depending on the provider and insurance status, annual monitoring adds $900 to $2,400 per year on top of medication cost.

The FDA label for mixed amphetamine salts includes a black box warning for abuse potential and a requirement for cardiovascular screening. FDA black box warning language is in the prescribing information at accessdata.fda.gov. Blood pressure and heart rate should be checked at each visit. A baseline ECG is recommended by the American Heart Association for patients with known or suspected cardiac conditions before initiating stimulant therapy. AHA scientific statement on cardiovascular evaluation before stimulant use: PubMed PMID 18443243.

Height and weight monitoring for pediatric patients adds another touchpoint. The AAP's clinical practice guidelines for ADHD (2019, updated 2023) recommend growth monitoring at each medication visit. Parents of children on mixed amphetamine salts should budget for these monitoring visits when calculating total annual ADHD treatment cost.

Florida's Prescription Drug Monitoring Program (PDMP), known as E-FORCSE (Electronic Florida Online Reporting of Controlled Substance Evaluation Program), requires prescribers to query the database before issuing each Schedule II prescription. E-FORCSE is administered by the Florida Department of Health. This requirement does not add patient cost directly but may extend appointment time and occasionally delay same-day prescribing.

The total annual cost of properly managed Adderall XR therapy in Florida, counting medication at $30 per month ($360/year) plus 12 follow-up visits at $100 average ($1,200/year), is approximately $1,560 for a cash-pay patient using generic plus discount coupon. That figure is the most accurate budget estimate for uninsured Florida adults in 2026.